Pygeum africanum, derived from the bark of the African cherry tree, has a long history of traditional use and has been the subject of modern clinical research, particularly in the area of prostate and urinary tract health. Studies indicate that pygeum bark extract may help support normal urinary function in men experiencing benign prostatic concerns, with several trials noting improvements in urinary flow and frequency. Research suggests that its beneficial properties may stem from a combination of phytosterols, pentacyclic triterpenes, and ferulic acid esters, which appear to contribute to its anti-inflammatory and antioxidant activity. While the body of evidence is encouraging, many researchers note that larger, more rigorous trials would help clarify its long-term effectiveness and optimal use within a broader wellness approach.
Compare this supplementResearch suggests that Pygeum africanum extract possesses meaningful anti-inflammatory properties, with in vitro and ...
View studies →Research suggests that Pygeum africanum shows promising results for prostate health across several areas, including p...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 200 mg | Daily | Prostate health, BPH symptom reduction | Higher end dose found in clinical trials evaluating urinary flow and symptom scores |
| Extract | 100 mg | Daily | Anti-inflammatory, lower urinary tract symptoms (LUTS) | Common single daily dose used in controlled studies; standardized lipophilic extract |
| Extract | 100–200 mg | Daily | Prostate health, benign prostatic hyperplasia (BPH) | Most commonly used range in clinical trials for BPH; standardized bark extract |
| Extract | 50–100 mg | Twice daily | Urinary tract health, BPH-related urinary symptoms | Split dosing regimen used in several RCTs; total 100–200 mg/day |